A BILL TO BE ENTITLED AN ACT RELATING TO THE HANDLING OF ANTINEOPLASTIC AGENTS TO PREVENT DISEASE AND INJURY CAUSED BY EXPOSURE.
Amends GS 95-174, the definitions section of the Hazardous Chemicals Right to Know Act, by adding two new terms and definitions, antineoplastic drug and hazardous drugs.
Enacts new GS 95-199 (Handling of dangerous drugs), providing that the Commissioner of Labor (Commissioner) must adopt rule requirements by January 1, 2015, for the handling of antineoplastic and other hazardous drugs in health care facilities. Rulemaking must consider input from a variety of stakeholders, including hospitals. Rules adopted must be consistent with and not exceed provisions adopted by the National Institute for Occupational Safety and Health alert on the dangers of exposures to antineoplastic and other hazardous drugs in health care facilities. The Commissioner will investigate complaints and enforce these requirements in accordance with the provisions of this Part.
© 2021 School of Government The University of North Carolina at Chapel Hill
This work is copyrighted and subject to "fair use" as permitted by federal copyright law. No portion of this publication may be reproduced or transmitted in any form or by any means without the express written permission of the publisher. Distribution by third parties is prohibited. Prohibited distribution includes, but is not limited to, posting, e-mailing, faxing, archiving in a public database, installing on intranets or servers, and redistributing via a computer network or in printed form. Unauthorized use or reproduction may result in legal action against the unauthorized user.